This DNA vaccine-induced protective humoral and cellular immune responses, which delayed the onset of spontaneous Neu-driven mammary carcinomas and improved tumor-free survival of HER-2/Neu-driven mammary carcinoma in mice 99. Here, ERBB2 is linked to breast carcinoma.